| Michael J Hartmann, MD | |
|
1000 Mineral Point Ave, Janesville, WI 53548 | |
| (608) 756-6111 | |
| (608) 756-6177 |
| Full Name | Michael J Hartmann |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 23 Years |
| Location | 1000 Mineral Point Ave, Janesville, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013073253 | NPI | - | NPPES |
| HARTMMI4 | Other | WI | MERCYCARE INSURANCE |
| 1013073253 | Other | WI | BCBSWI |
| 1013073253 | Medicaid | WI | |
| 000054176-K400095937 | Other | WI | WI MEDICARE |
| 036109982 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 036-109982 (Illinois) | Secondary |
| 207P00000X | Emergency Medicine | 60901-20 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Edward Hospital | Naperville, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Edward Hospital | 0042108110 | 98 |
News Archive
Ceregene, Inc., a biopharmaceutical company, reported today that its scientists and collaborators have published new experimental findings in support of its Parkinson's disease program which appeared as the lead article in the current issue of Movement Disorders. The publication reports the first evidence that gene transfer can provide targeted expression of a neurotrophic factor, i.e., neurturin or NRTN, intended to restore and preserve dying neurons.
Over the last decade the popularity of soaps and cleaning products claiming to have anti-bacterial properties has mushroomed as consumers are persuaded, by clever marketing, that they offer a defense against household illnesses.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of cardiorenal disease, today announced that the U.S. Patent and Trademark Office has issued a patent for the use of Neutrolin for preventing infection and clotting in hemodialysis catheters.
Embla and Covidien have entered into a definitive agreement under which Embla will acquire Covidien's Sleep Diagnostic business. This includes the sleep diagnostic products sold under the Sandman(TM) brand name. Financial terms of the transaction were not disclosed. Completion of the sale is subject to customary closing conditions.
Relaxing limits on take-home doses of methadone-;a medication used to treat opioid addiction-;does not appear to lead to worse treatment outcomes, according to a new study led by Washington State University researchers.
› Verified 6 days ago
| Entity Name | Edward Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013969013 PECOS PAC ID: 0042108110 Enrollment ID: O20040309001279 |
News Archive
Ceregene, Inc., a biopharmaceutical company, reported today that its scientists and collaborators have published new experimental findings in support of its Parkinson's disease program which appeared as the lead article in the current issue of Movement Disorders. The publication reports the first evidence that gene transfer can provide targeted expression of a neurotrophic factor, i.e., neurturin or NRTN, intended to restore and preserve dying neurons.
Over the last decade the popularity of soaps and cleaning products claiming to have anti-bacterial properties has mushroomed as consumers are persuaded, by clever marketing, that they offer a defense against household illnesses.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of cardiorenal disease, today announced that the U.S. Patent and Trademark Office has issued a patent for the use of Neutrolin for preventing infection and clotting in hemodialysis catheters.
Embla and Covidien have entered into a definitive agreement under which Embla will acquire Covidien's Sleep Diagnostic business. This includes the sleep diagnostic products sold under the Sandman(TM) brand name. Financial terms of the transaction were not disclosed. Completion of the sale is subject to customary closing conditions.
Relaxing limits on take-home doses of methadone-;a medication used to treat opioid addiction-;does not appear to lead to worse treatment outcomes, according to a new study led by Washington State University researchers.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael J Hartmann, MD 1000 Mineral Point Ave, Janesville, WI 53548-2940 Ph: (608) 756-6111 | Michael J Hartmann, MD 1000 Mineral Point Ave, Janesville, WI 53548 Ph: (608) 756-6111 |
News Archive
Ceregene, Inc., a biopharmaceutical company, reported today that its scientists and collaborators have published new experimental findings in support of its Parkinson's disease program which appeared as the lead article in the current issue of Movement Disorders. The publication reports the first evidence that gene transfer can provide targeted expression of a neurotrophic factor, i.e., neurturin or NRTN, intended to restore and preserve dying neurons.
Over the last decade the popularity of soaps and cleaning products claiming to have anti-bacterial properties has mushroomed as consumers are persuaded, by clever marketing, that they offer a defense against household illnesses.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of cardiorenal disease, today announced that the U.S. Patent and Trademark Office has issued a patent for the use of Neutrolin for preventing infection and clotting in hemodialysis catheters.
Embla and Covidien have entered into a definitive agreement under which Embla will acquire Covidien's Sleep Diagnostic business. This includes the sleep diagnostic products sold under the Sandman(TM) brand name. Financial terms of the transaction were not disclosed. Completion of the sale is subject to customary closing conditions.
Relaxing limits on take-home doses of methadone-;a medication used to treat opioid addiction-;does not appear to lead to worse treatment outcomes, according to a new study led by Washington State University researchers.
› Verified 6 days ago
Dr. Michael V Coogan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6000 | |
Sean William Marquis, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6611 Fax: 608-756-6177 | |
Dr. Karl A Nibbelink, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6611 | |
Christopher M. Koenig, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6611 Fax: 608-756-6177 | |
Dr. Martin Fedko, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6611 Fax: 608-756-6177 | |
Stephen L Merrill, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3524 E Milwaukee St, Janesville, WI 53546 Phone: 608-756-7100 Fax: 608-756-4700 |